DK0905254T3 - Fremgangsmåde til fremstilling af en lavemolekylær - Google Patents
Fremgangsmåde til fremstilling af en lavemolekylærInfo
- Publication number
- DK0905254T3 DK0905254T3 DK98117722T DK98117722T DK0905254T3 DK 0905254 T3 DK0905254 T3 DK 0905254T3 DK 98117722 T DK98117722 T DK 98117722T DK 98117722 T DK98117722 T DK 98117722T DK 0905254 T3 DK0905254 T3 DK 0905254T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- molecular weight
- low molecular
- low
- weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Lubricants (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19743135A DE19743135A1 (de) | 1997-09-30 | 1997-09-30 | Biologisch verträgliche niedermolekular Polyethylenimine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0905254T3 true DK0905254T3 (da) | 2006-08-21 |
Family
ID=7844109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98117722T DK0905254T3 (da) | 1997-09-30 | 1998-09-18 | Fremgangsmåde til fremstilling af en lavemolekylær |
Country Status (19)
Country | Link |
---|---|
US (2) | US8003734B2 (da) |
EP (1) | EP0905254B1 (da) |
JP (1) | JP4399042B2 (da) |
KR (1) | KR19990030290A (da) |
AR (1) | AR015726A1 (da) |
AT (1) | ATE324397T1 (da) |
AU (1) | AU758239B2 (da) |
BR (1) | BR9803982A (da) |
CA (1) | CA2249058A1 (da) |
CY (1) | CY1105109T1 (da) |
CZ (1) | CZ310598A3 (da) |
DE (2) | DE19743135A1 (da) |
DK (1) | DK0905254T3 (da) |
ES (1) | ES2264180T3 (da) |
HU (1) | HUP9802157A3 (da) |
ID (1) | ID20973A (da) |
PL (1) | PL328910A1 (da) |
PT (1) | PT905254E (da) |
TR (1) | TR199801933A2 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19956029A1 (de) * | 1999-11-22 | 2001-05-23 | Aventis Pharma Gmbh | Trägersysteme enthaltend Hüllsubstanzen mit enzymatisch abspaltbaren Seitengruppen |
DE19960206A1 (de) * | 1999-12-14 | 2001-07-19 | Frank Czubayko | Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung |
ATE326499T1 (de) * | 2000-02-18 | 2006-06-15 | Centelion | Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen |
FR2805271B1 (fr) * | 2000-02-18 | 2002-04-26 | Aventis Pharma Sa | Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations |
US6696038B1 (en) * | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
DE10145134A1 (de) * | 2000-10-09 | 2002-05-16 | Bayer Ag | Komplexe zur Einführung von Nukleinsäuren in Zellen |
JP2004510829A (ja) * | 2000-10-09 | 2004-04-08 | バイエル アクチェンゲゼルシャフト | 核酸を細胞内に転移させるための複合体 |
WO2003038103A1 (en) * | 2001-10-29 | 2003-05-08 | Atso Raasmaja | Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
US7824910B2 (en) | 2001-11-29 | 2010-11-02 | Nippon Shokubai Co., Ltd. | Method of transducing a protein into cells |
US20040087024A1 (en) * | 2002-02-22 | 2004-05-06 | Insert Therapeutics, Inc. | Carbohydrate-modified polymers, compositions and uses related thereto |
US20040048260A1 (en) * | 2002-09-10 | 2004-03-11 | Fu-Hsiung Chang | Transfection of nucleic acid |
US20040138154A1 (en) | 2003-01-13 | 2004-07-15 | Lei Yu | Solid surface for biomolecule delivery and high-throughput assay |
WO2004083450A2 (en) * | 2003-03-21 | 2004-09-30 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Hyperbranched dendron and methods of synthesis and use thereof |
JP2007043972A (ja) * | 2005-08-10 | 2007-02-22 | Tokyo Institute Of Technology | アパタイト粒子及びその作製方法、遺伝子−アパタイト粒子複合体及びその作製方法、並びに遺伝子導入方法及び遺伝子導入用キット |
US20080145893A1 (en) * | 2006-09-17 | 2008-06-19 | Excellegene Sa | Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection |
JP2010535264A (ja) * | 2007-07-31 | 2010-11-18 | ポリプラス トランスフェクション | トランスフェクション目的の直鎖ポリエチレンイミン(pei)を製造するための方法及びその方法で得られた直鎖pei |
FR2928373B1 (fr) * | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
WO2010125544A1 (en) | 2009-04-30 | 2010-11-04 | Genetic Immunity Kft. | Immunogenic nanomedicine composition and preparation and uses thereof |
EP4089169A1 (en) | 2009-10-12 | 2022-11-16 | Larry J. Smith | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
US10722462B2 (en) * | 2014-12-10 | 2020-07-28 | Council Of Scientific And Industrial Research | Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs |
JP6873418B2 (ja) * | 2016-11-11 | 2021-05-19 | 国立大学法人北陸先端科学技術大学院大学 | 遺伝子導入された細胞の製造方法及びポリエチレンイミンの置換体ポリマー |
EP3548890B1 (en) | 2016-12-01 | 2024-03-27 | Norbert Gretz | Means and methods for visualization of tissue structures |
CN112237633B (zh) * | 2020-10-22 | 2023-06-27 | 林君玉 | 一种pei/on复合物及其制备方法和用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2182306A (en) * | 1935-05-10 | 1939-12-05 | Ig Farbenindustrie Ag | Polymerization of ethylene imines |
NL45673C (da) * | 1935-05-11 | |||
DE2530042C3 (de) * | 1975-07-04 | 1982-04-22 | Institut neftechimičeskogo sinteza imeni A.V. Topčieva Akademii Nauk SSSR, Moskva | Verfahren zur Herstellung von linearem Polyäthylenimin |
US4032480A (en) * | 1975-07-11 | 1977-06-28 | David Solomonovich Zhuk | Method of producing linear polyethylenimine |
GB2128625B (en) * | 1982-10-07 | 1986-01-08 | Inst Neftechimicheskogo Sintez | Method for preparing branched polyethylenimine |
US4599400A (en) * | 1984-12-18 | 1986-07-08 | The Dow Chemical Company | Star/comb-branched polyamide |
GB8621337D0 (en) * | 1986-09-04 | 1986-10-15 | Agricultural Genetics Co | Non-radioactive nucleic acid hybridization probes |
US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
US6036955A (en) | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
RU2127125C1 (ru) * | 1994-03-07 | 1999-03-10 | Дзе Дау Кемикал Компани | Биологически активные и/или целевые дендримерные конъюгаты |
FR2722506B1 (fr) * | 1994-07-13 | 1996-08-14 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucleiques, preparation et utilisations |
EP0844891A4 (en) * | 1995-08-11 | 2004-05-06 | Dow Chemical Co | CONJUGATES OF HYPER-BRANCHED COMB POLYMERS |
EP0851838A2 (en) * | 1995-09-18 | 1998-07-08 | Delta Chemical Corporation | Polyaluminum chlorides and polyaluminum chlorosulfates methods and compositions |
DE19605279A1 (de) * | 1996-02-13 | 1997-08-14 | Hoechst Ag | Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung |
US5962429A (en) * | 1996-11-22 | 1999-10-05 | University Of Iowa | Complexes of adenovirus with cationic molecules |
DE19649645A1 (de) | 1996-11-29 | 1998-06-04 | Hoechst Ag | Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen |
US5830730A (en) * | 1997-05-08 | 1998-11-03 | The Regents Of The University Of California | Enhanced adenovirus-assisted transfection composition and method |
-
1997
- 1997-09-30 DE DE19743135A patent/DE19743135A1/de not_active Withdrawn
-
1998
- 1998-09-18 PT PT98117722T patent/PT905254E/pt unknown
- 1998-09-18 ES ES98117722T patent/ES2264180T3/es not_active Expired - Lifetime
- 1998-09-18 DE DE59813507T patent/DE59813507D1/de not_active Expired - Lifetime
- 1998-09-18 AT AT98117722T patent/ATE324397T1/de active
- 1998-09-18 DK DK98117722T patent/DK0905254T3/da active
- 1998-09-18 EP EP98117722A patent/EP0905254B1/de not_active Expired - Lifetime
- 1998-09-28 CZ CZ983105A patent/CZ310598A3/cs unknown
- 1998-09-28 AR ARP980104829A patent/AR015726A1/es unknown
- 1998-09-28 ID IDP981293A patent/ID20973A/id unknown
- 1998-09-28 TR TR1998/01933A patent/TR199801933A2/xx unknown
- 1998-09-28 HU HU9802157A patent/HUP9802157A3/hu unknown
- 1998-09-29 CA CA002249058A patent/CA2249058A1/en not_active Abandoned
- 1998-09-29 BR BR9803982-2A patent/BR9803982A/pt not_active IP Right Cessation
- 1998-09-29 AU AU87148/98A patent/AU758239B2/en not_active Ceased
- 1998-09-30 PL PL98328910A patent/PL328910A1/xx unknown
- 1998-09-30 JP JP27863998A patent/JP4399042B2/ja not_active Expired - Fee Related
- 1998-09-30 KR KR1019980040775A patent/KR19990030290A/ko not_active Application Discontinuation
-
2002
- 2002-10-07 US US10/265,539 patent/US8003734B2/en not_active Expired - Fee Related
-
2006
- 2006-07-26 CY CY20061101036T patent/CY1105109T1/el unknown
-
2011
- 2011-07-18 US US13/185,436 patent/US20110306656A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH11187874A (ja) | 1999-07-13 |
DE19743135A1 (de) | 1999-04-01 |
AU758239B2 (en) | 2003-03-20 |
EP0905254A3 (de) | 2002-01-02 |
CA2249058A1 (en) | 1999-03-30 |
PT905254E (pt) | 2006-08-31 |
EP0905254B1 (de) | 2006-04-26 |
ES2264180T3 (es) | 2006-12-16 |
HUP9802157A3 (en) | 2003-02-28 |
US20030027784A1 (en) | 2003-02-06 |
CZ310598A3 (cs) | 1999-04-14 |
HUP9802157A2 (hu) | 1999-06-28 |
DE59813507D1 (de) | 2006-06-01 |
PL328910A1 (en) | 1999-04-12 |
BR9803982A (pt) | 2000-03-28 |
JP4399042B2 (ja) | 2010-01-13 |
KR19990030290A (ko) | 1999-04-26 |
US20110306656A1 (en) | 2011-12-15 |
AR015726A1 (es) | 2001-05-16 |
ATE324397T1 (de) | 2006-05-15 |
TR199801933A2 (xx) | 1999-04-21 |
US8003734B2 (en) | 2011-08-23 |
ID20973A (id) | 1999-04-01 |
CY1105109T1 (el) | 2009-11-04 |
EP0905254A2 (de) | 1999-03-31 |
HU9802157D0 (en) | 1998-12-28 |
AU8714898A (en) | 1999-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0905254T3 (da) | Fremgangsmåde til fremstilling af en lavemolekylær | |
DK1032566T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0790226T3 (da) | Fremgangsmåde til fremstilling af methanol | |
NO980288D0 (no) | Gassfasepolymerisasjonsprosess | |
DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
DK1038008T3 (da) | Fremgangsmåde til fremstilling af EGIII-lignende enzymer | |
DE69832369D1 (de) | Hämofiltrationssystem | |
DK0812845T3 (da) | Fremgangsmåde til fremstilling af sildenafil | |
DK1123284T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0906784T4 (da) | Fremgangsmåde til fremstilling af bundne zeolitter | |
DK1005517T3 (da) | Fremgangsmåde til fremstilling af diglycerider | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK0768310T3 (da) | Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater | |
DK0996642T3 (da) | Fremgangsmåde til fremstilling af heparin | |
DK1027315T3 (da) | Fremgangsmåde til fremstilling af n-butanol | |
DK0877738T3 (da) | Fremgangsmåde til fremstilling af phenylimidazolidinderivater | |
DK0970939T3 (da) | Fremgangsmåde til fremstilling af methanol | |
ATE386058T1 (de) | Polymerisationsverfahren | |
DK0864564T3 (da) | Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater | |
DK0973769T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
DK0970073T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
DK1203000T3 (da) | Fremgangsmåde til fremstilling af phosphonomethylglycin | |
DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer | |
DK1240173T3 (da) | Fremgangsmåde til fremstilling af N-phosphonomethylglycin |